Novo Nordisk (NYSE:NVO)and US telehealth company Hims & Hers (NYSE:HIMS) have announced a collaboration that will bring the Danish drugmaker’s weight-loss medications Wegovy and Ozempic to Hims & Hers ...

Chase found men are particularly likely to leave big sums of money sitting in current accounts which pay little or no ...

Novo Nordisk’s fair value estimate has been revised from DKK 376.59 to DKK 330.95, a shift that pulls the price target about 12% closer to updated earnings assumptions. Analysts describe this reset as ...

GH Research (NASDAQ:GHRS) draws attention after valuation update as biotechnology activity aligns with Nasdaq futures market trends.